Shenzhen Stock Exchange: Shanghai Junshi Biopharmaceutical moved into the list of securities eligible for the Hong Kong Stock Connect trading program.

Shenzhen Stock Exchange Announcement: Due to the end of the stable period of prices in the Hong Kong market and the corresponding A-share listing for more than 10 trading days, in accordance with the relevant provisions of the "Shenzhen Stock Exchange Shenzhen-Hong Kong Stock Connect Business Implementation Measures", the company's stock will be included in the list of Hong Kong Stock Connect eligible securities from June 20, 2025.